| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/13/2009 | US20090203041 Bmp4 inhibitors |
| 08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090203035 Fluorescent proteins with increased photostability |
| 08/13/2009 | US20090203034 Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways |
| 08/13/2009 | US20090203033 Test and model for alzheimer's disease |
| 08/13/2009 | US20090203027 Assays for Detecting T2R76 Taste Modulatory Compounds |
| 08/13/2009 | US20090203026 Methods and compositions for targeting secretory lysosomes |
| 08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
| 08/13/2009 | US20090203016 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 08/13/2009 | US20090202992 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 08/13/2009 | US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer |
| 08/13/2009 | US20090202987 Canis sphingosine 1-phosphate receptor isoform 2 |
| 08/13/2009 | US20090202653 Compositions and method for enhancing proteoglycan production |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/13/2009 | US20090202607 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202587 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof |
| 08/13/2009 | US20090202585 Tat-based tolerogen compositions and methods for making and using same |
| 08/13/2009 | US20090202584 Treatment of epstein-barr virus-associated diseases |
| 08/13/2009 | US20090202579 Methods and compositions for treating and preventing malaria (2) |
| 08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/13/2009 | US20090202557 Compositions and methods for crystallizing antibody fragments |
| 08/13/2009 | US20090202555 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202538 F11 receptor (f11r) antagonists as therapeutic agents |
| 08/13/2009 | US20090202533 Treatment and prophylaxis of th2 mediated disorders |
| 08/13/2009 | US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202523 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202522 Use of goat serum for veterinary treatment |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | US20090202494 Combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/13/2009 | US20090202489 Adenoviruses mutated in the va genes for cancer treatment |
| 08/13/2009 | US20090202477 Methods of treating infections using il-21 |
| 08/13/2009 | US20090202475 Compositions and methods for treatment of microbial disorders |
| 08/13/2009 | US20090202472 Molecules and chimeric molecules thereof |
| 08/13/2009 | US20090202449 Use of osteopontin in dental formulations |
| 08/13/2009 | US20090202441 Compositions and methods to prevent cancer with cupredoxins |
| 08/13/2009 | US20090202440 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 08/13/2009 | US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090202429 Methods for testing anti-thrombotic agents |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure |
| 08/13/2009 | CA2714378A1 Treatment of chronic pain with zinc finger proteins |
| 08/13/2009 | CA2714276A1 Recombinant bacteria with e. coli hemolysin secretion system and increased expression and/or secretion of hlya, process of manufacturing and uses thereof |
| 08/13/2009 | CA2714121A1 Selection of rna-aptamers as anti-malaria agents |
| 08/13/2009 | CA2713871A1 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 08/13/2009 | CA2713850A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | CA2713400A1 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 08/13/2009 | CA2712805A1 Method and device for measuring the temperature of a hot spot in an oil-containing electric apparatus |
| 08/13/2009 | CA2712606A1 Modified leptin polypeptides and their uses |
| 08/13/2009 | CA2711585A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2088193A1 Novel shuttle vector |
| 08/12/2009 | EP2088192A1 Lytic enzyme inhibitor, lysis inhibitor, inhibitor of degradation of poly- gamma-glutamic acid, and method for production of poly- gamma-glutamic acid |
| 08/12/2009 | EP2088188A1 Direct expression of peptides into culture media |
| 08/12/2009 | EP2088157A1 Collagen peptide composition and food or beverage containing the same |
| 08/12/2009 | EP2088156A1 Use of adiponectin for the diagnosis and/or treatment of presbycusis |
| 08/12/2009 | EP2088155A1 Hetero-oligomeric HIV envelope proteins |
| 08/12/2009 | EP2088154A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/12/2009 | EP2087907A2 Method and system to remove cytokine inhibitor in patients |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087904A1 Therapeutic use of peptides derived from Bcl-XL protein in cancer patients |
| 08/12/2009 | EP2087361A1 Method for evaluating obesity controller |
| 08/12/2009 | EP2087351A2 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses |
| 08/12/2009 | EP2087152A1 Endometrial biomarkers |
| 08/12/2009 | EP2087125A1 Transgenic non-human animal |
| 08/12/2009 | EP2087120A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 08/12/2009 | EP2087119A1 Insect inhibition by plant serpin |
| 08/12/2009 | EP2087001A2 Alk1 receptor and ligand antagonists and uses thereof |
| 08/12/2009 | EP2087000A2 T cell therapies |
| 08/12/2009 | EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 08/12/2009 | EP2086998A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof |
| 08/12/2009 | EP2086997A1 Peptides having affinity for body surfaces and modified by attachment of charged block at least one extremity |
| 08/12/2009 | EP2086996A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 08/12/2009 | EP2086588A2 N-terminal pegylated prolactin receptor molecules |
| 08/12/2009 | EP2086581A2 Stabilization of vaccines by lyophilization |
| 08/12/2009 | EP2086577A2 Conjugates of plasmodium falciparum surface proteins as malaria vaccines |
| 08/12/2009 | EP2086576A2 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 08/12/2009 | EP2086575A2 Light-mediated anti-cell proliferative compositions and methods |
| 08/12/2009 | EP2086534A1 Compounds, compositions and methods for controlling invertebrate pests |
| 08/12/2009 | EP2086526A2 Induction of an immune response against dengue virus using prime-boost approach |
| 08/12/2009 | EP2086356A1 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use |
| 08/12/2009 | EP1984391A4 Pharmaceutical composition for treating vascular-related diseases comprising peptide |
| 08/12/2009 | EP1911764B1 Growth-stimulating polypeptides for use in fish and crustaceans |
| 08/12/2009 | EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 08/12/2009 | EP1856142B1 Synthesis of peptide t-1249 using peptide intermediate fragments |
| 08/12/2009 | EP1828403A4 Protein subcellular localization assays using split fluorescent proteins |
| 08/12/2009 | EP1819729B8 Method for producing carboxy-terminal amidified peptides |
| 08/12/2009 | EP1794190B1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |